|
2025
|
Invention
|
Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof.
Provi... |
|
|
Invention
|
Process for the preparation of vorasidenib.
Process for the preparation of vorasidenib using N,N... |
|
2024
|
Invention
|
Method of treating cancer in a patient with hepatic dysfunction. Provided are methods for treatin... |
|
|
Invention
|
Therapy for treating malignancies.
Provided are methods and compositions for treating cancers in... |
|
|
Invention
|
Cocrystal of an idh1 inhibitor, process of preparation thereof, pharmaceutical compositions there... |
|
|
Invention
|
Salts, cocrystals, pharmaceutical compositions thereof, and methods of treatment involving the sa... |
|
|
Invention
|
Tablet compositions.
Provided herein is a tablet comprising 2-methyl-1-[(4-[6-(trifluoromethyl)p... |
|
|
Invention
|
Methods of treating brain tumors using combination therapy.
Provided are methods of treating a b... |
|
|
G/S
|
Anti-cancer preparations; Biological preparations for the treatment of and prevention of cancer; ... |
|
2023
|
Invention
|
Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same.
Provid... |
|
|
Invention
|
Therapeutically active compounds and their methods of use. Provided are compounds useful for trea... |
|
|
Invention
|
Methods of use for trisubstituted benzotriazole derivatives. The present invention provides metho... |
|
|
Invention
|
Therapeutically active compounds and their methods of use.
Provided are compounds useful for tre... |
|
|
Invention
|
Methods of treating enhancing brain tumors using combination therapy.
Provided are methods for t... |
|
|
Invention
|
Methods of treating enhancing brain tumors using combination therapy. Provided are methods for tr... |
|
|
Invention
|
Therapeutically active compounds and their methods of use.
Provided are methods of treating a ca... |
|
|
Invention
|
Methods and compositions for cell-proliferation-related disorders.
Methods of treating and evalu... |
|
2022
|
Invention
|
Tablet compositions.
Provided herein is a tablet comprising 2-methyl-1-[(4-[-6-(trifluoromethyl)... |
|
|
Invention
|
Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same. Provide... |
|
|
Invention
|
Inhibitors of cellular metabolic processes. The present disclosure provides MAT2A inhibitor compo... |
|
2021
|
Invention
|
New organic compounds.
The present application provides MAT2A inhibitor compounds that are usefu... |
|
|
Invention
|
(heteo)aryl substituted pyrrolo-, pyrazolo- and triazolopyridazine derivates as mat2a inhibitors.... |
|
|
Invention
|
Menin inhibitors and methods of use for treating cancer. The present disclosure provides compound... |
|
|
Invention
|
Use of a dhodh inhibitor compound in combination cancer therapy. Provided herein are method of tr... |
|
|
Invention
|
Solid state forms of an organic compound. Provided herein are various solid state forms, includin... |
|
|
Invention
|
Combination therapies for use in treating cancer. The compound of Formula (I), or pharmaceuticall... |
|
|
Invention
|
Use of a dhodh inhibitor compound in combination cancer therapy.
Provided herein are method of t... |
|
|
Invention
|
Use of a dhodh inhibitor compound in combination cancer therapy. Provided herein a method of trea... |
|
|
Invention
|
Methods of treatment of malignancies.
Provided are methods and compositions for treating cancers... |
|
|
G/S
|
Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, bio... |
|
|
Invention
|
Inhibitors of cyclin-dependent kinases and uses thereof. Provided are novel compounds of Formula ... |
|
2020
|
Invention
|
Combination therapy for treating malignancies.
Provided are methods and compositions for treatin... |
|
|
Invention
|
Treatment of tumors incorporating mutant isocitrate dehydrogenase.
The present invention provide... |
|
|
Invention
|
A method for preparing ivosidenib and an intermediate thereof.
The present application relates t... |
|
2019
|
Invention
|
Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof. Provid... |
|
|
Invention
|
Ivosidenib forms and pharmaceutical compositions. Provided are formulations of ivosidenib includi... |
|
|
Invention
|
Heterobicyclic inhibitors of mat2a and methods of use for treating cancer. The present disclosure... |
|
|
Invention
|
Methods of use for trisubstituted benzotriazole derivatives. 3 are as defined herein.
|
|
2018
|
Invention
|
Methods of treating brain tumors using combination therapy. Provided are methods of treating a br... |
|
2016
|
G/S
|
anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, bio... |
